[ad_1]
TRIBUNNEWS.COM, JAKARTA – The Indonesian government imposed a ban on the entry of foreign nationals (WNAs) from across the country to Indonesia from January 1-14, 2021.
This is due to the appearance of a new mutated variant of the corona virus that has a very fast transmission power.
The policy was announced by the Minister of Foreign Affairs, Retno Marsudi, through the YouTube channel of the Secretariat of the Presidency, on Monday (12/28/2020).
Read also: The Covid-19 pandemic changes the Hammersonic festival calendar back to March 2021
In response to this, the cabinet meeting announced on December 28 decided to temporarily close it. I repeat to temporarily close from January 1 to 14, 2021, the entry of foreign citizens or foreigners from all countries to Indonesia, “said Retno.
The government requires foreigners arriving in Indonesia on December 28-31 to show negative results from the corresponding country of origin (PCR), a maximum of 2 x 24 hours before departure time.
Read also: A new wave of variants of the Corona virus has arrived from Spain to Canada
The letter must be attached at the time of the health check. If the test result is negative, the foreigner will carry out mandatory quarantine for five days from the date of arrival.
“After a five-day quarantine, recheck the RT-PCR and if the results are negative, visitors can continue their journey,” Retno continued.
Read also: To prevent the entry of the new variant of Covid, the government is asked to close access to the entrance from Malaysia and Singapore
As is known, a new variant of the SARS-CoV-2 corona virus has been identified in south-east England. The new variant that causes Covid-19 disease is called “VUI-202012/01”.
The new variant of the corona virus is said to be able to spread more quickly in parts of the UK. As of December 13, 2020, at least 1,108 confirmed cases of this variant had been identified in the southern and eastern regions of England.
While there is no evidence that this strain has any impact on disease severity, antibody response, or any effect on vaccine efficacy, cases due to new variants are increasing.
[ad_2]
